Thonzylamine hydrochloride

CAS No. 63-56-9

Thonzylamine hydrochloride( Anahist | Neohetramine hydrochloride | Novohetramin | Resistab | Thonzylamine HCl )

Catalog No. M27359 CAS No. 63-56-9

Thonzylamine hydrochloride is an anticholinergic and antihistamine used as an antipruritic.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 In Stock
10MG 71 In Stock
25MG 122 In Stock
50MG 179 In Stock
100MG 267 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Thonzylamine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Thonzylamine hydrochloride is an anticholinergic and antihistamine used as an antipruritic.
  • Description
    Thonzylamine hydrochloride is an anticholinergic and antihistamine used as an antipruritic.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Anahist | Neohetramine hydrochloride | Novohetramin | Resistab | Thonzylamine HCl
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TXA2R
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    63-56-9
  • Formula Weight
    322.84
  • Molecular Formula
    C16H23ClN4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.COc1ccc(CN(CCN(C)C)c2ncccn2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hirenallur-S DK, et al. Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets. Pulm Circ. 2012 Apr-Jun;2(2):193-200.
molnova catalog
related products
  • 11-Aminoundecanoic a...

    11-Aminoundecanoic acid is an alkyl chain based PROTAC linker can be used in the synthesis of PROTACs.

  • Ensituximab

    Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer.

  • NGI-1

    NGI-1 is a a cell-permeable inhibitor of oligosaccharyltransferase (OST).can effectively reduce virus infectivity without affecting cell viability.